ArticleOncotarget2017

A prognostic 4-gene expression signature for patients with HER2-negative breast cancer receiving taxane and anthracycline-based chemotherapy.

Pu Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.